Georgios Papazisis

Aristotle University of Thessaloniki - Department of Clinical Pharmacology

Greece

Clinical Trials Unit, Special Unit for Biomedical Research and Education, School of Medicine, Aristotle University

University Campus

S. Kyriakidi 1

Thessaloniki, Thessaloniki

Greece

SCHOLARLY PAPERS

8

DOWNLOADS
Rank 25,864

SSRN RANKINGS

Top 25,864

in Total Papers Downloads

2,780

SSRN CITATIONS

1

CROSSREF CITATIONS

0

Ideas:
“  Immunogenicity after the first dose and second dose of the BNT162b2 mRNA Covid-19 Vaccine: real-world evidence from Greek healthcare workers  ”

Scholarly Papers (8)

1.

Immunogenicity after the First Dose of the BNT162b2 mRNA COVID-19 Vaccine: Real-World Evidence from Greek Healthcare Workers

Number of pages: 10 Posted: 19 Feb 2021
G. Gennimatas General Hospital, Aristotle University of Thessaloniki - Department of Clinical Pharmacology, G. Gennimatas General Hospital, University of Bern - University Institute of Clinical Chemistry, G. Gennimatas General Hospital, G. Gennimatas General Hospital, G. Gennimatas General Hospital, G. Gennimatas General Hospital and Aristotle University of Thessaloniki - Department of Clinical Pharmacology
Downloads 1,246 (23,406)
Citation 2

Abstract:

Loading...

vaccine, BNT162b2, SARS-CoV-2, immunogenicity, healthcare workers, Greece, reactogenicity

2.

Anxiety During Pregnancy in the Era of the COVID-19 Pandemic

Number of pages: 18 Posted: 18 May 2020
Aristotle University of Thessaloniki - 3rd Department of Obstetrics and Gynaecology, Aristotle University of Thessaloniki - 3rd Department of Obstetrics and Gynaecology, Aristotle University of Thessaloniki - 3rd Department of Obstetrics and Gynaecology, Aristotle University of Thessaloniki - 3rd Department of Obstetrics and Gynaecology and Aristotle University of Thessaloniki - Department of Clinical Pharmacology
Downloads 406 (102,361)
Citation 7

Abstract:

Loading...

anxiety, pregnancy, covid-19, pandemic, stai questionnaire

3.

Second Dose of the BNT162b2 mRNA Vaccine in Greece: The Value of Timely Administration

Number of pages: 8 Posted: 01 Apr 2021
G. Gennimatas General Hospital, Aristotle University of Thessaloniki - Department of Clinical Pharmacology, University of Bern - University Institute of Clinical Chemistry, G. Gennimatas General Hospital, G. Gennimatas General Hospital, G. Gennimatas General Hospital, G. Gennimatas General Hospital, G. Gennimatas General Hospital and Aristotle University of Thessaloniki - Department of Clinical Pharmacology
Downloads 293 (146,091)

Abstract:

Loading...

BNT162b2 mRNA vaccine, immunogenicity, seropositive, Greece

4.

Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Elderly People Over 85 Years of Age in Greece

Number of pages: 10 Posted: 11 Jun 2021
G. Gennimatas General Hospital, University of Bern - University Institute of Clinical Chemistry, Aristotle University of Thessaloniki - Department of Clinical Pharmacology, G. Gennimatas General Hospital, G. Gennimatas General Hospital, G. Gennimatas General Hospital, G. Gennimatas General Hospital, affiliation not provided to SSRN, G. Gennimatas General Hospital, G. Gennimatas General Hospital and Aristotle University of Thessaloniki - Department of Clinical Pharmacology
Downloads 230 (185,637)
Citation 1

Abstract:

Loading...

BNT162b2 mRNA COVID-19 vaccine, immunogenicity, SARS-CoV-2, elderly over age 85, Greece

5.

Significant Increase of Antibody Titers After the 3rd Booster Dose of the Pfizer–BioNTech mRNA COVID-19 Vaccine in Healthcare Workers in Greece

Number of pages: 11 Posted: 04 Jan 2022
Konstantina Kontopoulou, Christos Nakas and Georgios Papazisis
G. Gennimatas General Hospital, University of Bern - University Institute of Clinical Chemistry and Aristotle University of Thessaloniki - Department of Clinical Pharmacology
Downloads 206 (205,910)

Abstract:

Loading...

Pfizer–BioNTech mRNA COVID-19 vaccine, immunogenicity, antibody titers, SARS-CoV-2, 3rd dose, booster dose, healthcare workers, Greece

6.

Antibody Titers 3-Months Post-Vaccination with the Pfizer/Biontech Vaccine in Greece

Number of pages: 13 Posted: 03 Sep 2021
G. Gennimatas General Hospital, University of Bern - University Institute of Clinical Chemistry, 1st Department of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, G. Gennimatas General Hospital, 1st Department of Pharmacology, School of Medicine, Aristotle University of Thessaloniki and Aristotle University of Thessaloniki - Department of Clinical Pharmacology
Downloads 206 (205,910)

Abstract:

Loading...

BNT162b2 mRNA Covid-19 vaccine; immunogenicity; neutralizing antibodies; SARS-CoV-2; 3-months post-vaccination; healthcare workers, Greece

7.

Evolution of Antibody Titers Up to 6 Months Post-Immunization With the BNT162b2 Pfizer/BioNTech Vaccine in Greece

Number of pages: 12 Posted: 15 Sep 2021
G. Gennimatas General Hospital, University of Bern - University Institute of Clinical Chemistry, Aristotle University of Thessaloniki - Department of Clinical Pharmacology, G. Gennimatas General Hospital, G. Gennimatas General Hospital and Aristotle University of Thessaloniki - Department of Clinical Pharmacology
Downloads 165 (249,677)

Abstract:

Loading...

BNT162b2 mRNA Covid-19 vaccine; immunogenicity; antibodies; SARS-CoV-2; 6-months post-vaccination; healthcare workers, Greece

8.

Antibody Titers After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Immunocompromised Adults in Greece: Necessity of a Fourth Dose

Number of pages: 16 Posted: 19 May 2022
G. Gennimatas General Hospital, University of Bern - University Institute of Clinical Chemistry, G. Gennimatas General Hospital and Aristotle University of Thessaloniki - Department of Clinical Pharmacology
Downloads 28 (642,868)

Abstract:

Loading...